Steven R Magnuson

This inventor holds 44 USPTO granted patents and 21 published patent applications, plus 2 CIPO patents and 25 EPO patents, primarily in Therapeutic Compounds. Top assignees: Genentech, Inc., Constellation Pharmaceuticals, Inc., Bayer Pharmaceuticals Corporation. Active years: 2002-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven R Magnuson. Retrieved from https://idiyas.com/inventor/steven-r-magnuson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 44 (Patent Applications = 21)

% Patents Active = 47.7

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 25 (Patent Applications = 32)

Average Co-Inventor Count = 9.9

ph-index = 6

Forward Citations = 172(Granted Patents)

Location History:

Hamden, CT (US) (2002 - 2005)
Wallingford, CT (US) (2005 - 2014)
Dublin, CA (US) (2012 - 2018)
South San Francisco, CA (US) (2016 - 2022)

Company Filing History:

Constellation Pharmaceuticals, Inc.

patents

8 out of 71

Bayer Pharmaceuticals Corporation

F. Hoffmann-La Roche Ag

patents

6. 1 out of 2,198

Smithkline Beecham Corporation

patents

7. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2022

Loading Chart...

Areas of Expertise:

Therapeutic Compounds

JAK Inhibitors

Pyrrolotriazine Derivatives

Aminoquinazoline Derivatives

Isoquinoline Derivatives

Pyrazolo Compounds

Cancer Treatments

Diabetes Treatments

Angiogenesis

Aurora Kinase Inhibition

Beta-3 Adrenoreceptor Agonists

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11247989 - Therapeutic compounds and uses thereof (2022-02-15),

2. 11168070 - Therapeutic compounds and uses thereof (2021-11-09),

3. 10696655 - Therapeutic compounds and uses thereof (2020-06-30),

4. 10358437 - Therapeutic compounds and uses thereof (2019-07-23),

5. 10308614 - Therapeutic compounds and uses thereof (2019-06-04),

6. 10280149 - Therapeutic compounds and uses thereof (2019-05-07),

7. 10258603 - Therapeutic compounds and uses thereof (2019-04-16),

8. 10206931 - Therapeutic compounds and uses thereof (2019-02-19),

9. 10202378 - Therapeutic compounds and uses thereof (2019-02-12),

10. 10202354 - Therapeutic compounds and uses thereof (2019-02-12),

11. 10183009 - Therapeutic compounds and uses thereof (2019-01-22),

12. 10155764 - Therapeutic compounds and uses thereof (2018-12-18),

13. 10150767 - Therapeutic compounds and uses thereof (2018-12-11),

14. 9855269 - Aminoquinazoline and pyridopyrimidine derivatives (2018-01-02),

15. 9763922 - Therapeutic compounds and uses thereof (2017-09-19),

Title: The Inventor Steven R Magnuson: Pioneering Innovations in Dublin, CA

Introduction: Steven R Magnuson is a distinguished inventor based in Dublin, CA, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Steven R Magnuson holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his versatility and ingenuity in inventing cutting-edge solutions.

Career Highlights: With a career spanning over two decades, Steven R Magnuson has worked with renowned research institutions and leading tech companies, consistently pushing the boundaries of innovation and creating solutions that have a lasting impact on society.

Collaborations: Throughout his career, Steven R Magnuson has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and knowledge-sharing that has led to the development of revolutionary technologies.

Conclusion: Steven R Magnuson's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in Dublin, CA and beyond.

Profile summary based on public USPTO records.